Home › Funds › MPM BioImpact LLC › FBRX
MPM BioImpact LLC position in FBRX
FORTE BIOSCIENCES INC
MPM BioImpact LLC reported holding 987,448 shares of FBRX (FORTE BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$21.0M, representing 1.28% of its reported portfolio and ranking #29 among its reported holdings. MPM BioImpact LLC has disclosed FBRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's FBRX position evolved
MPM BioImpact LLC first disclosed a stake in FBRX in Q1 2026 at 1,000,682 shares (US$25.9M). Across 2 filings, MPM BioImpact LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 987,448 shares valued at US$21.0M — a reduction of -13,234 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.00M | $25.92M | New |
| Q2 2026 | 987.45K | $20.98M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FBRX and 13F data
FBRX (FORTE BIOSCIENCES INC) is a company whose sector is not yet classified in our data. 70 other funds we track also report a position in FBRX — the largest reported positions include ORBIMED ADVISORS LLC (US$33.5M), Affinity Asset Advisors, LLC (US$24.3M), TCG Crossover Management, LLC (US$19.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FBRX
- ORBIMED ADVISORS LLC 1.58M sh · $33.53M · Q2 2026
- Affinity Asset Advisors, LLC 1.15M sh · $24.34M · Q2 2026
- TCG Crossover Management, LLC 920.00K sh · $19.55M · Q2 2026
- Integral Health Asset Management, LLC 675.00K sh · $14.34M · Q2 2026
- Cable Car Capital, LP 400.00K sh · $8.50M · Q2 2026
- Boxer Capital Management, LLC 274.50K sh · $5.83M · Q2 2026
- Trails Edge Capital Partners, LP 273.18K sh · $5.81M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 249.69K sh · $5.31M · Q2 2026
- Squadron Capital Management LLC 225.00K sh · $4.78M · Q2 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held FBRX?
MPM BioImpact LLC has disclosed FBRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is MPM BioImpact LLC's current position in FBRX?
As of Q2 2026, MPM BioImpact LLC holds 987.45K shares of FBRX (FORTE BIOSCIENCES INC), valued at $20.98M, representing 1.28% of its reported portfolio and ranking #29.
Has MPM BioImpact LLC been buying or selling FBRX?
In the latest 13F filing (Q2 2026), MPM BioImpact LLC reduced its position in FBRX.
Which other funds hold FBRX?
Other major institutional holders of FBRX include ORBIMED ADVISORS LLC, Affinity Asset Advisors, LLC, TCG Crossover Management, LLC, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.